A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex

NCT06924827 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Dravet Syndrome (DS)
Lennox-Gastaut Syndrome (LGS)

Interventions

DRUG: Epidiolex 100 mg/mL Oral Solution

Sponsor

Elizabeth Donner

Collaborators

[object Object]
[object Object]
[object Object]